Improving Informed Consent for Palliative Chemotherapy

Clinical trial NCT02282722 · COMPLETED

Trial details

NCT number: NCT02282722
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer Metastatic Pancreatic Cancer Unresectable Pancreatic Cancer

Start date: 2015-06-10
Primary completion: 2017-09-27
Enrollment: 216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.